文献速递外周动脉疾病

血栓保护装置与下肢血运重建斑块旋切术结局改善无关

Embolic Protection Devices are Not Associated with Improved Outcomes of Atherectomy for Lower Extremity Revascularization.
PubMed 文献 · Ann Vasc Surg · 2022-05-16

基于血管质量倡议外周血管介入数据库(2010-2018)分析,斑块旋切术中血栓保护装置使用率为23.3%(5,013/21,500),研究期间从8.8%升至22.7%(P=0.003)。倾向匹配后每组1,007例,围术期远端栓塞、技术成功及1年通畅率、截肢、再干预和死亡率均无显著差异,但使用血栓保护装置与更长透视时间相关。

要点

  • 斑块旋切术中血栓保护装置使用率从8.8%升至22.7%(P=0.003)。
  • 倾向匹配后两组围术期远端栓塞率无显著差异。
  • 1年原发通畅率、截肢、再干预及死亡率两组无差异。

核心结论

  • 血栓保护装置在斑块旋切术中应用增加,尤其见于间歇性跛行及股腘动脉病变患者,但似乎不影响结局。
  • 作者认为需要进一步研究以论证斑块旋切术中常规使用血栓保护装置所增加的额外费用和透视时间是否合理。

研究设计与样本

  • 基于血管质量倡议外周血管介入数据库(2010-2018)的回顾性分析。
  • 排除合并开放手术、急性肢体缺血、急诊状态、合并溶栓、缺失适应证、缺失血栓保护装置使用信息及缺失长期随访数据的患者。
  • 比较使用与未使用血栓保护装置的斑块旋切患者特征,并基于年龄、性别、种族、慢性阻塞性肺疾病、冠心病、终末期肾病、既往外周血管介入、适应证、紧急状态、TASC分类及病变解剖位置进行倾向匹配。
  • 倾向匹配后每组1,007例,比较围术期及1年结局。

主要发现

  • 血栓保护装置用于23.3%的斑块旋切术(n=5,013/21,500),使用率从8.8%升至22.7%(P=0.003)。
  • 未使用血栓保护装置者更多患终末期肾病(7.8% vs 5.2%,P<0.001)、组织缺失(31% vs 23.1%,P<0.001)、胫动脉介入(39.6% vs 23.3%,P<0.001)、治疗动脉数更多(1.78±0.92 vs 1.68±0.93,P=0.001)及病变更长(21.15±21.14 vs 19±20.27 cm,P=0.004)。
  • 使用血栓保护装置者更多为白人(81.1% vs 74%,P<0.001)、有吸烟史(80.6% vs 74.5%,P<0.001)、慢性阻塞性肺疾病(24.8% vs 21.6%,P<0.037)、冠心病(38.5% vs 33.2%,P=0.002)、既往经皮冠状动脉介入(24.3% vs 19.9%,P=0.005)、既往冠状动脉旁路移植(32.3% vs 24.9%,P<0.001)及既往外周血管介入(49.2% vs 45.1%,P=0.023)。
  • 倾向匹配后两组基线特征无显著差异,围术期远端栓塞率、技术成功、夹层、穿孔、出院回家及30天死亡率均无显著差异,但使用血栓保护装置与更长透视时间相关。
  • 1年原发通畅率、同侧小或大截肢、踝肱指数改善、再干预或死亡率两组间无差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Atherectomy is associated with a risk of distal embolization, but the role of embolic protection devices (EPDs) during atherectomy is not well-defined. This study examines the utilization and impact of EPD on the outcomes of atherectomy during peripheral vascular interventions (PVIs). METHODS: The annual trend in utilization of EPD during atherectomy in the Vascular Quality Initiative PVI files (2010-2018) was derived. Patients with concomitant open surgery, acute limb ischemia, emergent-status, concomitant thrombolysis, missing indication, missing EPD use, and missing long-term follow-up data were excluded. The characteristics of patients undergoing atherectomy with and without EPD were compared. Propensity matching based on age, gender, race, chronic obstructive pulmonary disease, coronary artery disease, end-stage renal disease, prior PVI, indication, urgent-status, TransAtlantic interSociety Consensus classification, and anatomical location of lesion was performed. The perioperative and 1-year outcomes of the matched groups were compared. RESULTS: EPD was used in 23.3% of atherectomy procedures (n = 5,013/21,500). The utilization of EPD with atherectomy increased from 8.8% to 22.7% (P = 0.003) during the study period. Patients undergoing atherectomy without EPD were more likely to have ESRD (7.8% vs. 5.2%; P < 0.001), tissue loss (31% vs. 23.1; P < 0.001), tibial intervention (39.6% vs. 23.3%; P < 0.001), higher number of arteries treated (1.78 ± 0.92 vs. 1.68 ± 0.93; P = 0.001), and longer length of lesion (21.15 ± 21.14 vs. 19 ± 20.27 cm; P = 0.004). Conversely, patients undergoing atherectomy with EPD were more likely to be White (81.1% vs. 74%; P < 0.001), have a history of smoking (80.6% vs. 74.5%; P < 0.001), chronic obstructive pulmonary disease (24.8% vs. 21.6%; P < 0.037), coronary artery disease (38.5% vs. 33.2%; P = 0.002), prior percutaneous coronary intervention (24.3% vs. 19.9%, P = 0.005), prior coronary artery bypass grafting (32.3% vs. 24.9%; P < 0.001), and prior PVI (49.2% vs. 45.1%; P = 0.023). After propensity matching, there were 1,007 patients in each group with no significant difference in baseline characteristics. There was no significant difference in short-term outcomes including the rate of distal embolization, technical success, dissection, perforation, discharge to home, and 30-day mortality. The use of EPD was, however, associated with longer fluoroscopy time. At 1-year, there was also no difference in primary patency, ipsilateral minor or major amputation, ankle brachial index improvement, reintervention, or mortality rate between patients who underwent atherectomy with and without EPD. CONCLUSIONS: EPD has been increasingly used in conjunction with atherectomy especially in patients with claudication and femoropopliteal disease. However, the use of EPD during atherectomy does not seem to impact the outcomes. Further research is needed to justify the additional cost and fluoroscopy time associated with the use of EPD during atherectomy.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Fereydooni A, Bai H, Baril D, et al. Embolic Protection Devices are Not Associated with Improved Outcomes of Atherectomy for Lower Extremity Revascularization. Ann Vasc Surg. 2022. PMID: 35589031. doi:10.1016/j.avsg.2022.04.045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。